Try one of the below options to narrow down your search.
 |
Documents may be browsed by date, eg; Today, May, 2013.
Past years can be browsed too, eg; 2012, 2011, 2010, 2009 ...
Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg; Media releases from 2013
Document tags (shown below the document date, eg; Schedule, SAForms, consultation ...) have highest priority when search results are ranked, followed by title, abstract and full text of document.
Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.
Remember to group or statements with parentheses if they are beside and statements.
Search examples
- consultation
- Search for consultations
- media and not antibiotics
- Search for media related documents that don't mention antibiotics.
- (media or consultation) and vaccines
- Search for media releases and consultation documents mentioning vaccinations.
Search term: Q
2010
PHARMAC documents that matched your search:
SA0967 - Endothelian receptor antagonists
(26 pages, 222 KB)
2010/03/23
“q Male q Female Applications must be complete and accompanied by supporting data where required”
ELIGIBILITY CRITERIA FOR PULMONARY ARTERIAL HYPERTENSION THERAPY Contents ELIGIBILITY CRITERIA FOR INITIATION OF PULMONARY ARTERIAL HYPERTENSION THERAPY ….. 2 Initial Application for Funding of Pulmonary Arterial Hypertension Treatments for Adults (and children aged over 10 years) …. 6 Renewal Application…
SA0968 - Phosphodieterase type 5 inhibitors - sildenafil
(26 pages, 222 KB)
2010/03/23
“q Male q Female Applications must be complete and accompanied by supporting data where required”
ELIGIBILITY CRITERIA FOR PULMONARY ARTERIAL HYPERTENSION THERAPY Contents ELIGIBILITY CRITERIA FOR INITIATION OF PULMONARY ARTERIAL HYPERTENSION THERAPY ….. 2 Initial Application for Funding of Pulmonary Arterial Hypertension Treatments for Adults (and children aged over 10 years) …. 6 Renewal Application…
SA0969 - Prostacyclin analogues - iloprost
(26 pages, 222 KB)
2010/03/23
“q Male q Female Applications must be complete and accompanied by supporting data where required”
ELIGIBILITY CRITERIA FOR PULMONARY ARTERIAL HYPERTENSION THERAPY Contents ELIGIBILITY CRITERIA FOR INITIATION OF PULMONARY ARTERIAL HYPERTENSION THERAPY ….. 2 Initial Application for Funding of Pulmonary Arterial Hypertension Treatments for Adults (and children aged over 10 years) …. 6 Renewal Application…
Schedule Update - effective 1 February 2010
(44 pages, 885 KB)
2010/01/18
“Q Q 200 .......................................................... 26, 38 Quetapel ............................................................ 40 Quetiapine.......................................................... 40 Quinine sulphate .......................................... 26, 38 R Ranbaxy”
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 February 2010 Cumulative for January and February 2010 Section H cumulative for December 2009, and January, February 2010 Contents Summary of PHARMAC decisions effective 1 February 2010 …. 3 Aromatase…
Schedule Update - effective 1 March 2010
(50 pages, 657 KB)
2010/02/18
“Q Q 200 .......................................................... 28, 44 Quetapel ............................................................ 46 Quetiapine.......................................................... 46 Quinine sulphate .......................................... 28, 44 R Ranbaxy”
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 March 2010 Cumulative for January, February and March 2010 Section H cumulative for December 2009, January, February and March 2010 Contents Summary of PHARMAC decisions effective 1 March 2010 …..…
Schedule Update - effective 1 April 2010
(54 pages, 707 KB)
2010/03/18
“Q Q 200 ................................................................ 38 Quinine sulphate ................................................ 38 R Ranbaxy Amoxicillin ..................................... 45, 47 Recombinant human growth”
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 April 2010 Cumulative for January, February, March and April 2010 Section H for April 2010 Contents Summary of PHARMAC decisions effective 1 April 2010 …. 3 Diclofenac sodium SR 75…
Section H - effective 1 March 2010
(106 pages, 623 KB)
2010/03/02
“Q 200 Q 300 Isentress 3.37 4.57 17.20 54.06 1,350.00 30 30 250 500 60 5 300 ml 1% 250 250 1% Dec-09 Apo-Quinne”
Pharmaceutical Management Agency Section H for Hospital Pharmaceuticals Effective 1 March 2010 New Zealand Pharmaceutical Schedule Contents Introducing PHARMAC …..2 Members of the PHARMAC Board ….2 Decision Criteria …2 PHARMAC and Section H of the Pharmaceutical Schedule ….3 The PHARMAC…
Schedule Update - effective 1 August 2010
(82 pages, 867 KB)
2010/07/20
“Q 300 ArrowRoxithromycin Asthalin Asthalin Duolin 2012 2012 2012 2012 2011 2012 2012 2012 2011 2011 2012 2011 2012 2012 Procaine”
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 August 2010 Cumulative for May, June, July and August 2010 Section H for August 2010 Contents Summary of PHARMAC decisions effective 1 August 2010 …. 3 Changes to various dispensing…
Schedule Update - effective 1 January 2011
(37 pages, 537 KB)
2010/12/16
“Q 300 Mycobutin Ropin ArrowRoxithromycin Salapin Asthalin Asthalin Duolin 2012 2013 2013 2012 2013 2012 2012 2012 2011 2012 2012 2011 2012 2011 2011 2011 Quinapril”
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 January 2011 Section H cumulative for December 2010 and January 2011 Contents Summary of PHARMAC decisions effective 1 January 2011 … 3 Pharmacy Brand Switch payments …. 5 Nicotine –…
Schedule Update - effective 1 October 2010
(68 pages, 803 KB)
2010/09/16
“Q 300 Mycobutin Ropin ArrowRoxithromycin Salapin Asthalin Asthalin Duolin 2012 2013 2013 2012 2013 2012 2012 2011 2012 2011 2012 2012 2011 2012 2011 2011 2011 Quinapril”
Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 October 2010 Section H cumulative for August, September and October 2010 Contents Summary of PHARMAC decisions effective 1 October 2010 ….. 3 Pharmaceutical co-payments remain unchanged … 6 Further topical…
